Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant. (PubMed, Clin Transplant) - Oct 27, 2025 - "LTV was effective and well-tolerated for primary CMV prophylaxis in an extra-renal transplant population and may be a safe alternative in patients experiencing sustained hematologic toxicities with (val)ganciclovir across all transplant groups."
Journal • Retrospective data • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Solid Organ Transplantation • Transplantation
|
|
A Osama Gaber; Alex W Rogers; Allison N Yun; Masayuki Nigo; R Mark Ghobrial; Suneri J Amin
|